NCT03700320 · Interventional trial
Study to Evaluate the Safety and Tolerability of Treatment With Atogepant 60 mg Daily for the Prevention of Migraine in Participants With Episodic Migraine
Overall registry status Completed
Phase 3
Conditions Episodic Migraine
Delaware Valley sites
- Clinical Research of Philadelphia, LLC · Philadelphia, PA · Philadelphia County
- Hassman Research Institutes · Berlin, NJ · Camden County
- Suburban Research Associates · Media, PA · Delaware County
First posted
Registry updated
Added to the directory